Release Details

TARRYTOWN, N.Y., Aug. 31, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

• Baird 2015 Healthcare Conference at 12:50 p.m. Eastern Time on Wednesday, September 9, 2015

• Morgan Stanley Global Healthcare Conference at 12:30 p.m. Eastern Time on Wednesday, September 16, 2015

• Bank of America Merrill Lynch Global Healthcare Conference at 10:25 a.m. Eastern Time on Thursday, September 17, 2015

The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, and atopic dermatitis. For additional information about the company, please visit www.regeneron.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-2015-investor-conference-presentations-300134653.html

SOURCE Regeneron Pharmaceuticals, Inc.